Skip to main content
Hardeep Phull, MD, Oncology, Escondido, CA

HardeepSinghPhullMDMS

Oncology Escondido, CA

Hematologic Oncology

Director of Oncology, Palomar Health Cancer Institute. Board Member, Palomar Health Foundation. Chief Medical Officer Council, Palomar Health Medical Group. Clinical Faculty and Instructor at University of California San Diego. Alumni Specialty Director, Cleveland Clinic Alumni Board of Directors

Dr. Phull is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Phull's full profile

Already have an account?

  • Office

    2125 Citracado Pkwy
    Ste 220
    Escondido, CA 92029
    Phone+1 760-740-2715
    Fax+1 858-939-6809

Summary

  • Dr. Hardeep Phull is an Oncologist specializing in Hematologic Oncology, based in Escondido, CA. He completed his residency in Internal Medicine at Scripps Clinic/Scripps Green Hospital and his fellowship in Hematology and Medical Oncology at the University of California Medical Center. He also holds a B.S. in Molecular Biology, an M.S. in Clinical and Translational Investigation, and an MD from the Cleveland Clinic Lerner College of Medicine. His experience covers a wide range of areas, including neuro-oncology, hospice and palliative medicine, and various types of cancers. Currently, he works as a Hematologist/Oncologist at Palomar Health and as a Clinical Instructor at The Rebecca and John Moores UCSD Cancer Center. Dr. Phull's contribution to the medical field is reflected in a series of publications and prestigious awards.

Education & Training

  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
  • The Scripps Research Institute (TSRI)
    The Scripps Research Institute (TSRI)MS, Clinical and Translational Investigation, KL2 Scholar, 2013 - 2015
  • Scripps Clinic/Scripps Green Hospital
    Scripps Clinic/Scripps Green HospitalResidency, Internal Medicine, 2011 - 2015
  • Cleveland Clinic Lerner College of Medicine
    Cleveland Clinic Lerner College of MedicineClass of 2011, MD
  • University of Arizona (UA), College of Science
    University of Arizona (UA), College of ScienceB.S., Molecular Biology, Minor in Spanish, Magna cum laude, 1999 - 2003

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2012 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Chief Fellow University of California San Diego, 2017-2018
  • Winner of Basic Science Poster Competition American College of Physicians (ACP) National Meeting, 2014
  • Scripps Clinic Medical Group (SCMG) Research and Education Award Scripps, 2014
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • FIT: Functional and imaging testing for patients with metastatic cancer  
    Eric J Roeland, H Phull, C Hagmann , C Sera, A D Dullea, A El-Jawahri, S Nelson, A Gallivan, J D Ma, R D Nipp, V E Baracos, Support Care Cancer, 9/29/2020
  • Severe disease on endoscopy and steroid use increase the risk for colonic perforation during colonoscopy in inflammatory bowel disease patients.  
    Udayakumar N, Kochhar GS, Phull HS, Venkatesh PGK, Hammel J, Remzi FH, Kiran RP, Shen B, J Crohns Colitis, 1/1/2012
  • Angiotensin II type 1 (AT-1) receptor inhibition partially prevents the urodynamic and detrusor changes associated with bladder outlet obstruction: a mouse model.  
    Comiter CV, Phull HS, BJU Int, 1/1/2012
  • Join now to see all

Abstracts/Posters

  • Severe disease on endoscopy and steroid use increase the risk for colonic perforation during colonoscopy in inflammatory bowel disease patients.
    Kochhar GS, Udayakumar N, Phull HS, Venkatesh PGK, Hammel J, Remzi FH, Kiran RP, Shen B, Poster Presentation (Inflammatory Bowel Disease Category) at the American College of Gastroenterol, 11/1/2011
  • Number of readmission risk factors predicts the rate and likelihood of readmission in patients with liver disease - a prospective study.
    Kochhar GS, Zain A, Phull HS, Lopez R, Rizk MK, Poster Presentation (Outcomes Research Category) at the American College of Gastroenterology 2011 , 10/31/2011
  • Random biopsies during colonoscopy in patients with primary sclerosing cholangitis and ulcerative colitis - does it impact clinical outcome?
    Udayakumar N, Kochhar GS, Venkatesh PGK, Phull HS, Hammel J, Kiran RP, Remzi FH, Shen B, Poster Presentation (Colon Category) at the American College of Gastroenterology 2011 Annual Scien, 10/30/2011
  • Join now to see all

Authored Content

  • Authentic Mentorship and Trainee Engagement: The ASH-a-Palooza Platform at the ASH Annual MeetingNovember 2024
  • Contention or Meaningful Reform? The Long-Awaited CMS Rules for Prior AuthorizationMay 2024
  • The Catch-22 of OncologyMay 2024
  • Health Care Access and Equity in Relation to Prostate CancerFebruary 2024
  • Medical Conferences Are an Opportunity to Nourish MentorshipsFebruary 2023
  • How the Post-COVID ASH Conference 2022 Provided a Platform to Nourish the Human Spirit with Work, Play, and FriendshipDecember 2022
  • Join now to see all

Press Mentions

  • The Doctor Will Tweet You Now
    The Doctor Will Tweet You NowJanuary 2nd, 2023
  • The Cancer Institute of Palomar Health
    The Cancer Institute of Palomar Health January 2nd, 2023
  • Leaders in Cancer Care
    Leaders in Cancer CareJanuary 2nd, 2023
  • Join now to see all

Professional Memberships

Other Languages

  • Spanish, Hindi